Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder

Cancer

Volumn 97, Issue 8, 2003, Pages 1876-1883

  Ramos, David ^a,c   Navarro, Samuel ^a   Villamón, Rafael ^b   Gil Salom, Manuel ^b   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

34 E12 antigen; Bladder neoplasms; CK20; Immunohistochemistry; Prognosis; Recurrence

Indexed keywords

ANTIGEN; CYTOKERATIN 20; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0037446135     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11265     Document Type: Article

References (15)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the bladder. Am J Surg Pathol. 1998;22:1435-1438.
2. Leblanc B, Duclos AJ, Bènard F, et al. Long-term follow-up of initial Ta grade I transitional cell carcinoma of the bladder. J Urol. 1999;162:1946-1950.
3. Cheng L, Neumann RM, Bostwick DG. Papillary urothelial neoplasms of low malignant potential. Cancer. 1999;86: 2102-2108.
4. Prout GR, Barton BA, Griffin PP, Friedell GH. Treated history of non-invasive grade 1 transitional cell carcinoma. J Urol. 1992;148:1413-1419.
5. Holmäng S, Hedelin H, Anderström C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low-grade papillary urothelial tumors. J Urol. 1999;162:702-707.
6. Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol. 1995;153:1823-1827.
7. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer. 2000;88:1663-1670.
8. Southgate J, Harnden P, Trejdosiewicz LK. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol. 1999;14:657-664.
9. Desai S, Lim SD, Jimènez RE, et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol. 2000;13:1315-1323.
10. Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. Mod Pathol. 2001;14:267-272.
11. Harnden P, Allam A, Joyce AD, Patel A, Selby P, Southgate J. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology. 1995;27:169-174.
12. Harnden P, Mahmood N, Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet. 1999;353:974-977.
13. Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol. 1996;78:870-875.
14. Helpap B, Köllermann J. Proliferative pattern of exophytic and superficially invasive and noninvasive low-grade urothelial carcinomas. Hum Pathol. 1999;30:145-150.
15. Helpap B, Köllermann J. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of urothelial tumors of the urinary bladder. Hum Pathol. 2000;31:745-750.